克隆性造血与晚发型血清阳性类风湿关节炎发病风险的关联
本研究在多生物库中探讨克隆性造血(CH)及其亚型CHIP和mCA与 incident RA 的关联,并检验补体的效应修饰。常染色体mCA和mLOY亦与血清阳性RA风险升高相关,遗传预测的C1r和C1s水平可减弱CHIP-血清阳性RA关联。
要点
- CHIP与血清阳性RA风险升高相关(合并HR 1.26),主要由DNMT3A突变CHIP和晚发型RA驱动。
- 常染色体mCA和mLOY与血清阳性RA风险升高相关,但与血清阴性RA无关。
- 遗传预测的C1r和C1s水平较高可减弱CHIP与血清阳性RA的关联。
核心结论
- 年龄相关克隆性造血(包括DNMT3A-CHIP、常染色体mCA和mLOY)是血清阳性RA而非血清阴性RA的风险因素。
研究设计与样本
- 在NIH All of Us、Vanderbilt BioVU和UK Biobank中检测CHIP,在UK Biobank中检测mCA,采用统一的高特异性表型算法识别血清阳性RA(SPRA)和血清阴性RA(SNRA)参与者,使用年龄尺度生存模型评估CH对 incident RA 风险的影响,并通过与遗传预测补体蛋白水平的交互模型检验效应修饰。
主要发现
- 在612,989名参与者中,30,840名有CHIP,1,535名发生 incident SPRA,1,090名发生 incident SNRA。
- 遗传预测的C1r和C1s水平较高可减弱CHIP与SPRA的关联。
临床怎么用
- 对于携带CHIP(尤其DNMT3A突变)、常染色体mCA或mLOY的老年人,应关注血清阳性RA的发病风险。
- 经典补体通路(C1r/C1s)可能修饰CHIP与血清阳性RA的关联,提示补体水平或可作为风险分层参考。
局限性
- 研究结果主要基于遗传关联和观察性设计,不能直接推断因果关系。
- CHIP和mCA的检测平台及表型算法在不同生物库间可能存在差异。
- 遗传预测补体水平的效应修饰分析需进一步功能验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Clonal hematopoiesis (CH), defined by acquired driver mutations in hematopoietic stem cells, is associated with many inflammatory diseases of aging. We investigated whether CH and its subtypes, CH of indeterminate potential (CHIP) and mosaic chromosomal alteration (mCA), are associated with incident rheumatoid arthritis (RA) and whether complement modifies these associations. METHODS: CHIP was detected in NIH All of Us, Vanderbilt BioVU, and UK Biobank; mCA was detected in UK Biobank. A harmonized, high-specificity phenotyping algorithm was applied across biobanks to identify participants with seropositive and seronegative RA (SPRA and SNRA). Age-scale survival models assessed the effect of CH on risk of incident RA. Effect modification was tested with interaction models with genetically predicted complement protein levels. RESULTS: Among 612,989 participants, 30,840 had CHIP, 1,535 had incident SPRA, and 1,090 had incident SNRA. CHIP was associated with an increased risk of incident SPRA (pooled hazard ratio [HR] 1.26; confidence interval [CI] 1.03-1.52; P = 2.3 × 10-2), driven primarily by DNMT3A-mutated CHIP and late-onset RA (HR 1.45; CI 1.13-1.96; P = 3.6 × 10-3) but not SNRA. Autosomal mCA and mosaic loss of chromosome Y (mLOY) were associated with an increased risk of incident SPRA (HR 2.12 and 2.85; CI 1.18-3.8 and 1.57-5.19; P = 1.2 × 10-2 and 6.1 × 10-4) but not SNRA. Higher genetically predicted levels of C1r and C1s attenuated the CHIP-SPRA association. CONCLUSION: Age-related CH, including DNMT3A-CHIP, autosomal mCA, and mLOY, are risk factors for incident SPRA but not SNRA, supporting a genotype- and serostatus-specific link between somatic mutation and RA, with the classical complement pathway as a potential modifier.
引用
- Zhao K, Pershad Y, Heimlich JB, et al. Association of Clonal Hematopoiesis With Incident, Late-Onset, Seropositive Rheumatoid Arthritis. Arthritis Rheumatol. 2026. PMID: 41847932. doi:10.1002/art.70133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。